Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue				$ 900,000
Operating expenses:
Research and development (net of collaboration funding of $1,648,631 and $1,025,935 in the three months ended June 30, 2022 and 2021, respectively, and of $4,648,002 and $1,312,038 in the six months ended June 30, 2022 and 2021, respectively)	$ 3,426,773	$ 1,361,287	$ 6,598,412	3,367,192
General and administrative (net of collaboration funding of $3,257,701 and $602,534 in the three months ended June 30, 2022 and 2021, respectively, and of $5,629,876 and $602,534 in the six months ended June 30, 2022 and 2021, respectively)	3,638,073	2,268,508	7,513,674	5,782,649
Total operating expenses	7,064,846	3,629,795	14,112,086	9,149,841
Loss from operations	(7,064,846)	(3,629,795)	(14,112,086)	(8,249,841)
Other income (expense), net:
Costs of debt issuance	(200,129)		(1,368,194)
Changes in fair value of debt instruments	4,729,460		3,767,060
Interest and other income (expense) , net	(139,234)	564,914	(142,072)	524,751
Foreign currency transaction gain (loss)	7,713	(4,156)	9,252	44,748
Total other income (expense), net	4,397,810	560,758	2,266,046	569,499
Net loss	$ (2,667,036)	$ (3,069,037)	$ (11,846,040)	$ (7,680,342)
Net loss per share - basic	$ (0.17)	$ (0.21)	$ (0.80)	$ (0.54)
Net loss per share - diluted	$ (0.64)	$ (0.21)		$ (0.54)
Weighted average common shares outstanding - basic	15,273,707	14,310,244	14,794,637	14,225,551
Weighted average common shares outstanding - diluted	14,310,244	14,310,244		14,225,551